EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
213
PAGES
459
EDITION
16
PRICE
USD 5600
CODE
MCP-1795
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Intranasal Drug Delivery Market to Reach $75.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Intranasal Drug Delivery estimated at US$49.5 Billion in the year 2020, is projected to reach a revised size of US$75.4 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Liquid Delivery Devices, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$31.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Powder Delivery Devices segment is readjusted to a revised 7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $20.8 Billion, While China is Forecast to Grow at 8.4% CAGR
The Intranasal Drug Delivery market in the U.S. is estimated at US$20.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.6 Billion by the year 2027.
Pressurized Metered Dose Inhalers Segment to Record 6.4% CAGR
In the global Pressurized Metered Dose Inhalers segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$7 Billion in the year 2020 will reach a projected size of US$10.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.5% CAGR through the analysis period.
SELECT PLAYERS
AptarGroup, Inc.; AstraZeneca Plc.; Becton Dickinson and Company; GlaxoSmithKline Plc.; Johnson & Johnson Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer, Inc.
SEGMENTS
» Product Type (Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers, Other Product Types) » Application (Respiratory Disorders, Neurological Disorders, Pain Management, Other Applications)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of Covid-19 and a Looming Global Recession |
2020: A Year of Disruption & Transformation |
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021? |
Promising Intranasal Vaccines to Nip COVID-19 Virus at Point of Entry |
Influencer Market Insights |
World Market Trajectories |
Intranasal Drug Delivery – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Intranasal Drug Delivery: A Prelude |
EXHIBIT: Leading Indications and APIs Amenable to Nasal Drug Delivery |
Regional Market Analysis |
Why Nasal Application is Garnering Notable Attention for Drug Delivery |
Limitations of Intranasal Drug Delivery |
Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range |
Drug Delivery Pathways Related to the Nasal Cavity |
Systemic delivery and Local Delivery Routes |
Differences between Systemic Delivery and Local Effects |
Challenges Involved In Formulating Nasal Drugs |
Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier |
Nose-to-Brain Drug Delivery: An Evolving Area of Interest |
Factors Inhibiting Nose-to-Brain Transportation of Drugs |
Bioavailability: An Important Facet of Intranasal Drug Delivery |
Traditional Vs. Advanced Intranasal Drug Formulation Types |
Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application |
Select FDA-Approved Nasal Products Compound (Trade Name) Indication Dosage Form Year |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Rise in Prevalence of COPD Drives Opportunities |
EXHIBIT: Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group |
Pharmaceutical and Medical Device Companies Vie to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients |
EXHIBIT: Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries |
The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis |
The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment |
Intranasal Corticosteroids : A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease |
Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage |
Manufacturers Focus on Improved Nasal Delivery Platforms |
Controlled Release Technology is the Buzz Word |
Research on Nanocarrier-Based Intranasal Drug Delivery Systems Picks Up Pace |
Potential Role in Treatment and Management of Coronavirus Infection |
Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight |
Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era |
EXHIBIT: Top Nasal Inhalers, Sprays, and Drops Brands in the US (2019): Percentage Share Breakdown of Dollar Sales |
Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications |
Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery |
Intranasal Therapeutics Delivery: A High Potential Method for Treating CNS Diseases |
Researchers Develop Nasal Spray Treatment for Parkinson’s Disease |
Future Opportunities in CNS Space |
Intranasal Delivery of Stem Cells: A Primary Strategy for Treatment of CNS Disorders |
Intranasal Delivery of Stem Cells: Limitations |
EXHIBIT 10: Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries |
Intranasal Delivery of Peptide-Based Pharmaceuticals |
Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace |
Select List of Nasal Biologics Available in the Market |
Benefits of Bi-Directional Nasal Drug Delivery |
Rise in Interest in Preservative-free Nasal Spray Formulations |
Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
Appendix: List of Select Intranasal Drugs in Phase III Clinical Trials |
List of Select Intranasal Drugs for Pain Management in Phase III Clinical Trials |
Select Intranasal Drugs for Cancer in Phase III Clinical Trials |
Select Intranasal Drugs for Diabetes in Phase III Clinical Trials |
Select Intranasal Drugs for Nasal Polyps in Phase III Clinical Trials |
Select Intranasal Drugs for Depression in Phase III Clinical Trials |
Select Intranasal Drugs for Chronic Sinusitis in Phase III Clinical Trials |
Select Intranasal Drugs for Migraine in Phase III Clinical Trials |
Intranasal Drugs for Allergic Rhinitis in Phase III Clinical Trials |
Select Intranasal Drugs for Diabetes Mellitus in Phase III Clinical Trials |
Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials |
Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Liquid Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Powder Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Pressurized Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Respiratory Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
World 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
USA 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
USA 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Canada 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Canada 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
JAPAN |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Japan 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Japan 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
CHINA |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
China 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
China 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
EUROPE |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Europe 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Europe 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Europe 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2021 & 2027 |
FRANCE |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
France 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
France 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
GERMANY |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Germany 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Germany 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Italy 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Italy 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
UNITED KINGDOM |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
UK 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
UK 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Spain 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Spain 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Russia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Russia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Europe 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Europe 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
ASIA-PACIFIC |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2021 & 2027 |
AUSTRALIA |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Australia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Australia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
INDIA |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
India 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
India 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
South Korea 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
South Korea 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
LATIN AMERICA |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Latin America 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Latin America 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Latin America 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2021 & 2027 |
ARGENTINA |
Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Argentina 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Argentina 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
BRAZIL |
Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Brazil 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Brazil 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
MEXICO |
Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Mexico 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Mexico 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
REST OF LATIN AMERICA |
Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Latin America 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Latin America 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
MIDDLE EAST |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Middle East 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Middle East 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Middle East 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2021 & 2027 |
IRAN |
Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Iran 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Iran 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
ISRAEL |
Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Israel 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Israel 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
SAUDI ARABIA |
Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Saudi Arabia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Saudi Arabia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
UNITED ARAB EMIRATES |
UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
UAE 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
UAE 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
REST OF MIDDLE EAST |
Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Middle East 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Rest of Middle East 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
AFRICA |
Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Africa 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR |
Africa 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com